| 1. |
Hoffmann TC, Erueti C, Glasziou PP. Poor description of non-pharmacological interventions: analysis of consecutive sample of randomised trials. BMJ, 2013, 347: f3755.
|
| 2. |
Glasziou P, Meats E, Heneghan C, et al. What is missing from descriptions of treatment in trials and reviews? BMJ, 2008, 336(7659): 1472-1474.
|
| 3. |
Hoffmann TC, Walker MF, Langhorne P, et al. What's in a name? The challenge of describing interventions in systematic reviews: analysis of a random sample of reviews of non-pharmacological stroke interventions. BMJ Open, 2015, 5(11): e009051.
|
| 4. |
Page MJ, Shamseer L, Altman DG, et al. Epidemiology and reporting characteristics of systematic reviews of biomedical research: a cross-sectional study. PLoS Med, 2016, 13(5): e1002028.
|
| 5. |
Hoffmann TC, Glasziou PP, Boutron I, et al. Better reporting of interventions: template for intervention description and replication (TIDieR) checklist and guide. BMJ, 2014, 348: g1687.
|
| 6. |
Liberati A, Altman DG, Tetzlaff J, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ, 2009, 339: b2700.
|
| 7. |
Hoffmann TC, Oxman AD, Ioannidis JP, et al. Enhancing the usability of systematic reviews by improving the consideration and description of interventions. BMJ, 2017, 358: j2998.
|
| 8. |
Shamseer L, Moher D, Clarke M, et al. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation. BMJ, 2015, 349: g7647.
|
| 9. |
Wells M, Williams B, Treweek S, et al. Intervention description is not enough: evidence from an in-depth multiple case study on the untold role and impact of context in randomised controlled trials of seven complex interventions. Trials, 2012, 13: 95.
|
